Found: 74
Select item for more details and to access through your institution.
Observational study to predict the efficacy and optimal duration of nivolumab treatment in patients with previously treated advanced or recurrent non-small cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 2, p. 153, doi. 10.1093/jjco/hyac159
- By:
- Publication type:
- Article
Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1261, doi. 10.1093/jjco/hyab072
- By:
- Publication type:
- Article
Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 8, p. 909, doi. 10.1093/jjco/hyaa067
- By:
- Publication type:
- Article
Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 1, p. 29, doi. 10.1093/jjco/hyy179
- By:
- Publication type:
- Article
Pemetrexed-related interstitial lung disease reported from post marketing surveillance (malignant pleural mesothelioma/non-small cell lung cancer).
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 4, p. 350, doi. 10.1093/jjco/hyx010
- By:
- Publication type:
- Article
Diffuse Alveolar Hemorrhage as a Fatal Adverse Effect of Bevacizumab: An Autopsy Case.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 5, p. 497, doi. 10.1093/jjco/hyu023
- By:
- Publication type:
- Article
Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 4, p. 635, doi. 10.1513/AnnalsATS.202311-941OC
- By:
- Publication type:
- Article
Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung.
- Published in:
- Journal of Pathology, 2003, v. 200, n. 1, p. 82, doi. 10.1002/path.1321
- By:
- Publication type:
- Article
Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 2, p. 217, doi. 10.1007/s10637-017-0435-2
- By:
- Publication type:
- Article
Correction to: Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 12, p. 1585, doi. 10.1007/s10147-023-02414-x
- By:
- Publication type:
- Article
A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 376, doi. 10.1016/j.cllc.2020.12.009
- By:
- Publication type:
- Article
Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFR Mutation Positive Stage III Non–small-cell Lung Cancer: LAURA Trial in Progress.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 371, doi. 10.1016/j.cllc.2020.11.004
- By:
- Publication type:
- Article
Treatment Rationale and Design of a Phase III Study of Afatinib or Chemotherapy in Patients with Non-small-cell Lung Cancer Harboring Sensitizing Uncommon Epidermal Growth Factor Receptor Mutations (ACHILLES/TORG1834).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Isolated Brain Metastases as the First Relapse After the Curative Surgical Resection in Non-Small-Cell Lung Cancer Patients With an EGFR Mutation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non—Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2017, v. 18, n. 1, p. 100, doi. 10.1016/j.cllc.2016.08.003
- By:
- Publication type:
- Article
Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan.
- Published in:
- Lung Cancer: Targets & Therapy, 2017, v. 8, p. 191, doi. 10.2147/LCTT.S140491
- By:
- Publication type:
- Article
A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987647
- By:
- Publication type:
- Article
A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987647
- By:
- Publication type:
- Article
Rationale and protocol design for the TORG1835/NEXT-SHIP study: a phase II study of carboplatin, etoposide and nintedanib for unresectable limited/extensive disease small cell lung cancer with idiopathic pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920923431
- By:
- Publication type:
- Article
A phase II study of atezolizumab for pretreated advanced/recurrent non-small cell lung cancer with idiopathic interstitial pneumonias: rationale and design for the TORG1936/AMBITIOUS study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920923431
- By:
- Publication type:
- Article
Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pharmacotherapy for Advanced Non-Small Cell Lung Cancer with Performance Status 2 without Druggable Gene Alterations: Could Immune Checkpoint Inhibitors Be a Game Changer?
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4861, doi. 10.3390/cancers14194861
- By:
- Publication type:
- Article
Current Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 3979, doi. 10.3390/cancers13163979
- By:
- Publication type:
- Article
Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L).
- Published in:
- Molecular Oncology, 2021, v. 15, n. 1, p. 126, doi. 10.1002/1878-0261.12841
- By:
- Publication type:
- Article
Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1275, doi. 10.1007/s10637-013-9941-z
- By:
- Publication type:
- Article
Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Comparison between next‐generation sequencing and multiplex polymerase chain reaction assays for nonsmall‐cell lung cancer molecular diagnosis.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7162
- By:
- Publication type:
- Article
Randomized phase II trial of S‐1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 2, p. 626, doi. 10.1002/cam4.3641
- By:
- Publication type:
- Article
Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 3, p. 599
- By:
- Publication type:
- Article
A case of severe arthralgia with malignant mesothelioma-associated hypertrophic osteoarthropathy.
- Published in:
- Clinical Case Reports, 2016, v. 4, n. 11, p. 1057, doi. 10.1002/ccr3.709
- By:
- Publication type:
- Article
Phase I Study of Cisplatin Analogue Nedaplatin, Paclitaxel, and Thoracic Radiotherapy for Unresectable Stage III Non-Small Cell Lung Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2007, v. 37, n. 3, p. 175, doi. 10.1093/jjco/hym008
- By:
- Publication type:
- Article
Mutation profile and programmed death ligand 1 status of patients with non‐small cell lung cancer diagnosed with "adenocarcinoma" and "non‐small cell carcinoma favor adenocarcinoma".
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 6, p. 458, doi. 10.1111/1759-7714.15214
- By:
- Publication type:
- Article
Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 22, p. 3217, doi. 10.1111/1759-7714.14685
- By:
- Publication type:
- Article
A case of lung adenocarcinoma with a novel CD74‐ROS1 fusion variant identified by comprehensive genomic profiling that responded to crizotinib and entrectinib.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 18, p. 2504, doi. 10.1111/1759-7714.14093
- By:
- Publication type:
- Article
Tissue surface area and tumor cell count affect the success rate of the Oncomine Dx Target Test in the analysis of biopsy tissue samples.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 194, doi. 10.1111/1759-7714.13743
- By:
- Publication type:
- Article
Tumor invasion in the central airway is a risk factor for early‐onset checkpoint inhibitor pneumonitis in patients with non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3576, doi. 10.1111/1759-7714.13703
- By:
- Publication type:
- Article
An open-label feasibility study of nintedanib combined with docetaxel in Japanese patients with locally advanced or metastatic lung adenocarcinoma after failure of first-line chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Safety and efficacy of S-1 in combination with carboplatin in non-small cell lung cancer patients with interstitial lung disease: a pilot study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Association between soluble immune mediators and tumor responses in patients with nonsmall cell lung cancer treated with anti‐PD‐1 inhibitor.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 5, p. 1170, doi. 10.1002/ijc.31923
- By:
- Publication type:
- Article
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 10, p. 1679, doi. 10.1038/s41416-024-02615-9
- By:
- Publication type:
- Article
Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
- Published in:
- Biomedicines, 2024, v. 12, n. 8, p. 1831, doi. 10.3390/biomedicines12081831
- By:
- Publication type:
- Article
Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation Sequencing.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 3, p. 391, doi. 10.3390/diagnostics11030391
- By:
- Publication type:
- Article